• Archives of Pharmacal Research
• /
• 제27권5호
• /
• pp.547-553
• /
• 2004

The pyrrolizidine alkaloids (PAs), contained in a number of traditional remedies in Africa and Asia, show wide variations in metabolism between animal species but little work has been done to investigate differences between animal strains. The metabolism of the PA senecionine (SN) in Fischer 344 (F344) rats has been studied in order to compare to that found in the previously investigated Sprague-Dawley (SO) rats (Drug Metab. Dispos. 17: 387, 1989). There was no difference in the formation of ($\pm$) 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine (DHP, bioactivation) by hepatic microsomes from either sex of SO and F344 rats. However, hepatic microsomes from male and female F344 rats had greater activity in the Noxidation (detoxication) of SN by 88% and 180%, respectively, when compared to that of male and female SD rats. Experiments conducted at various pH showed an optimum pH of 8.5, the optimal pH for flavin-containing monooxygenase (FMO), for SN N-oxidation by hepatic microsomes from F344 females. In F344 males, however, a bimodal pattern was obtained with activity peaks at pH 7.6 and 8.5 reflecting the possible involvement of both cytochrome P450 (CYP) and FMO. Use of specific inhibitors (SKF525A, 1-benzylimidazole and methimazole) showed that the N-oxide of SN was primarily produced by FMO in both sexes of F344 rats. In contrast, SN N-oxide formation is known to be catalyzed mainly by CYP2C11 rather than FMO in SD rats. This study, therefore, demonstrated that there were substantial differences in the formation of SN N-oxide by hepatic microsomes from F344 and SD rats and that this detoxification is catalyzed primarily by two different enzymes in the two rat strains. These findings suggest that significant variations in PA biotransformation can exist between different animal strains.

• Biomolecules & Therapeutics
• /
• 제10권3호
• /
• pp.193-199
• /
• 2002

The arylamine N-acetyltransferases (NATs) are a family of enzymes that N-acetylate mylhydrazines and arylamines through transfer of an acetyl group from acetyl coenzyme A. This activity was found to vary among individuals as a Mendalian trait and the basis of the genetic differences in human NAT activity is one of the best of the genetic studied examples of pharmacogenetic variation. The classical N-acetylation polymorphism is regulated at the NAT2 locus, which segregates individuals into rapid, intermediate, and slow acetylator phenotypes. In this study, the relationship between NAT2 activity phenotype using HPLC:UV assay for the determination of dapsone and monoacetyldapsone in plasma and NAT2 genotype by PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) was investigated in the F2 hybrid (Fischer 344 vs Wistar-Kyoto) rats. Three Common mutant alleles at the NAT2 gene locus have been identified in the F2 generation progeny of Fischer 344 rats as raid acetylator and Wistar-Kyoto rats as slow acetylator segregated into three modes (low, intermediates, and high) with simple Mendelian inheritance. The metabolic activity of NAT2 of the intermediate and rapid acetylators is significant1y greater than slow acetylator, but the metabolic activity of rapid acetylator is not significantly different from Intermediate type. Therefore, we could observe that complete trimodal NAT2 genotypic alleles and incomplete trimodal NAT2 metabolic phenotypic distribution in tile F2 hybrid rats. These observations suggest that the relationships between NAT2 genotype and metabolic phenotype exists and F2 hybrid (Fischer 344: Wistar-Kyoto) animal models about NAT2 polymorphism might be applied in the toxicity and pharmacogenetic studies of arylamine drugs and carcinogens.

• 한국수의병리학회:학술대회논문집
• /
• 한국수의병리학회 2002년도 추계학술대회초록집
• /
• pp.12-20
• /
• 2002

1. 질병명 : Interstitial pneumonia 2. 본질명의 개요 역사 및 역학 Michael R Elwell, Joel F Mahler, G N Rao: “ Have You Seen This\ulcorner" ; Inflammatory Lesions in the Lungs of Rats. Toxicologic Pathology, 25: 529-531, 1997. Male and female F344 rats, approximately 19 weeks old, from prechronic toxicity studies performed for NTP/NIEHS over a period of several years at different laboraories located throughout the US. The rats were supplied by 2 different production colonies located in the eastern and western areas of the US. Gross findings ㆍ In some rats the lesions were noted as pale or tan foci in the lungs Microscopic findings ㆍ A prominent increase in perivascular lymphocytes ㆍ A variable increase in the amount of peribronchiolar lymphoid tissues ㆍ Frequently an inflammatory cell exudate within the alveolar spaces ㆍ Focal hyperplasia of alveolar type 2 cells Similar lung lesions were not observed in B6C3F1 mice concurrently on study with affected rats. Similar lung lesions were not observed in F344 rats at the end of 2-year NTP studies. Virus, mycoplasma, bacterial serology, bacterial culture, protozoal identification: negative EM: ㆍ No virus particles were identified. ㆍ Rod shaped bacteria were observed in the alveolar spaces. ㆍ Bacteria were not observed in the bronchi/ bronchioles of rats with alveolar organism. (omitted)

• 대한수의학회지
• /
• 제48권4호
• /
• pp.401-411
• /
• 2008

This study was performed to evaluate repeated-dose oral toxicities of Flos lonicerae extract in Fischer 344/n rats. Flos lonicerae was administered orally to rats at dose levels of 0, 37, 111, 333, 1,000 and 2,000 mg/kg/day. Each group consisted of 10 rats of each gender. The Flos lonicerae extract was given once a day, 5 times a week, for 90 day repeatedly. This study was conducted in accordance with the Protocol of Korea National Toxicology Program and The Standards of Toxicity Study for Medicinal Products. In the present study, there were no toxicologically significant changes in mortality, clinical signs, body weight gains, ophthalmoscopy, urine analysis, hematology, serum biochemistry, necropsy findings, organ weights, histopathology, estrus cycle and sperm examination of all animals treated with Flos lonicerae extract. These results suggest that the oral no observed adverse-effect level of the test item, Flos lonicerae extract, in rats is higher than 2,000 mg/kg/day in both genders. The target organs were not established.

• 대한수의학회지
• /
• 제49권1호
• /
• pp.23-34
• /
• 2009

This study was performed to evaluate repeated-dose oral toxicities of Chelidonium majus extract in Fischer 344/N rats. Chelidonium majus extract was administered orally to rats at dose levels of 0, 25, 74, 222, 666 and 2,000 mg/kg/day. Each group consisted of 10 rats of each gender. The Chelidonium majus extract was given once a day, 5 times a week, for 90 day repeatedly. This study was conducted in accordance with the Protocol of Korea National Toxicology Program (issued by National Institute of Toxicological Research) and The Standards of Toxicity Study for Medicinal Products (issued by Korea Food and Drug Administration). In the present study, There were no toxicologically significant changes in mortality, clinical signs, body weight gains, ophthalmoscopy, urine analysis, hematology, serum biochemistry, necropsy findings, organ weights, histopathology, estrus cycle and sperm examination of all animals treated with Chelidonium majus extract. These results suggest that the oral no observed adverse-effect level of the test item, Chelidonium majus extract, in rats is higher than 2,000 mg/kg/day in both genders. The target organs were not established.

• 생명과학회지
• /
• 제17권6호통권86호
• /
• pp.859-866
• /
• 2007

본 연구는 임신횐쥐에서 운동이 혈중 인슐린과 렙틴 농도, 그리고 골격근의 GLUT-4와 VAMP-2단백질 발현에 변화를 조사하기 위하여 수행되었다. 본 연구에서 비임신 횐쥐에 비해 임신 횐쥐에서 혈중 인슐린 농도가 유의하게 증가되었고, 렙틴 농도는 유의하게 감소하는 것으로 나타났다. 임신횐쥐에게 달리기 운동을 적용한 결과 임신으로 증가된 인슐린 농도를 유의하게 감소시키면서 렙틴 농도의 감소를 억제시키는 것으로 나타났다. 골격근에서 GLUT-4와 VAMP-2 단백질 발현량을 조사한 결과 비임신 횐쥐에 비해 임신 횐쥐에서 이러한 단백질 발현이 유의하게 감소되었지만, 임신 중 달리기운동을 경험한 횐쥐에서 GLUT-4와 VAMP-2 발현 모두 유의하게 증가되는 것으로 나타났다. 이와 잘이 임신으로 인한 혈중 인슐린 및 렙틴의 변화가 골격근에서 당을 근조직으로 흡수하는 신호 전달 경로와 수송체의 발현 손상과 연관되어있음을 보여주는 것이다. 하지만 임신 횐쥐에서 달리기 운동은 인슐린과 렙틴 농도의 변화를 완화시킴으로써 골격근의GLUT-4와 VAMP-2발현을 유의하게 증가시키는 것으로 나타났다.

• 대한수의학회지
• /
• 제43권4호
• /
• pp.683-688
• /
• 2003

Caffeine (1,3,7-trimethylxanthine), a central nervous system stimulant, is contained in various foods, beverages and over-the-counter medications. Sulfadimethoxine (SDM) is one of the anti-thyroid agents and induces proliferation of thyroid capsule in two stage thyroid carcinogenesis model using N-bis(2-hydroxypropyl)nitrosamine (DHPN). In this study, we examined the effect of caffeine on fibrous proliferation of thyroid capsule in DHPN and SDM-treated rats. Five-week-old male F344 rats were given a single subcutaneous injection of DHPN (2,800 mg/kg, body weight). Starting one week thereafter, SDM (1,000 ppm in drinking water) with or without caffeine (1,500 ppm in diet) was administered for 12 weeks. All animals were autopsied and histopathological examination of the thyroid glands was performed. Thyroid follicular proliferative changes were induced in all rats treated with DHPN+SDM. In addition, the proliferation of perithyroidal fibrous tissue and pleomorphic thyroid follicular cells within the capsule were observed in DHPN+SDM treated group. Caffeine would not be related to these lesions in this experimental condition. although pentoxifylline, a methyl xanthine derivative, has an anti fibrotic effects.

• 생명과학회지
• /
• 제14권5호
• /
• pp.741-746
• /
• 2004

본 연구는 운동강도 차이에 따른 카페인 구강 투여가 STZ-유발 당뇨 쥐 가자미근에서 GLUT-4와 GRP-78 단백질 발현에 미치는 영향을 규명하기 위하여 F344계 수컷 횐쥐를 무작위 표본추출에 의하여 당뇨유발군(n=6), 당뇨유발-카페인 투여군(n=6), 당뇨유발-카페인투여 저강도운동군(n=6), 당뇨유발-카페인투여 중강도운동군(n=6), 그리고 당뇨유발-카페인투여 고강도 운동군(n=6)으로 분류하였다. 저강도 운동은 트레드밀 경사도 0%에서 8 m/min 속도로, 중강도 운동은 트레드밀 경사도 0%에서 16 m/min 속도로, 고강도운동은 트레드밀 경사도 0%에서 25 m/min속도로 30분간 1회 운동을 실시하였다. GLUT4단백질 발현은 당뇨군에 비해서 당뇨유발군-카페인 투여군과 당뇨유발-카페인투여 저강도 운동군에서 차이가 없었으며, 당뇨유발-카페인투석 중강도 운동군에서는 다소 감소하였으나 당뇨유발-카페인투여 고강도 운동군에서 증가하였다. GRP-78 단백질 발현은 당뇨군에 비해서 당뇨유발-카페인투여 저강도 운동군, 당뇨유발-카페인투여 중강도 운동군, 그리고 당뇨유발-카페인투석 고강도 운동군에서 감소하였으나, 당뇨유발-카페인 투여군에서는 다소 증가한 것으로 나타났다 고강도 일회성 운동이 인슐린 민감도를 개선시켜 인슐린 요구량을 낮추는데 이러한 효과는 내형질세망에서 세포막으로의 GLUT-4 단백질의 전이와 GLUT-4 단백질 양의 증가 때문이다. 운동군에서의 GRP-78 단백질이 감소된 기전은 정확히 밝힐 수는 없지만, 카페인으로 인한 지질 동원이 운동 시 작업근의 세포에 많은 에너지를 공급하여 세포가 받는 스트레스를 완화시켜 주었기 때문이라고 추측된다.

• 생명과학회지
• /
• 제19권2호
• /
• pp.213-218
• /
• 2009

본 연구에서는 F344계 흰쥐를 대상으로 8주간 저강도 운동군과 고강도 운동군으로 나누어 수영운동을 실시하여, 갈색지방조직 내 UCP-1과 UCP-3mRNA 발현을 관찰하고 혈당 및 인슐린 수준이 어떠한 변화를 나타내는지 알아보았다. 그 결과 저강도 수영을 실시한 그룹이 대조군과 고강도 운동그룹보다 갈색지방조직 내 UCP-1과 UCP-3 mRNA 발현이 증가되는 것을 관찰하였으며, 고강도 수영군에서 대조군 보다 인슐린 수준이 낮게 나타났으나 혈당에서는 유의한차가 나타나지 않았다. 하지만 저강도 수영군에서 대조군보다 혈당 및 인슐린 수준이 유의하게 감소하는 것을 관찰하였다. 이러한 결과는 저강도 수영운동이 갈색지방조직 내 UCP-1과 UCP-3mRNA 발현을 증가시키고, 당대사를 활성화하여 인슐린민감도를 개선시킬 수 있음을 보여주는 결과이다.

• 생명과학회지
• /
• 제15권1호
• /
• pp.87-93
• /
• 2005

본 연구에서는 Streptozotocin-유발 당뇨 쥐를 대상으로 8주 동안 운동 강도에 따른 혈당, 인슐린, 골격근 내 GLUT-4 발현 량과 GRP-78 발현량 변화를 관찰함으로써 당뇨 쥐의 혈당을 낮추는데 효과적인 운동 강도는 무엇이며, 기전적인 원인은 무엇인지를 밝히고자 실시되었다. 본 연구에서 Streptozotocin으로 당뇨를 유발시킨 흰쥐를 대상으로 운동 강도 처치에 따른 GLUT-4발현 량을 비교한 결과, 기본적으로 당뇨가 유발된 흰쥐의 GLUT-4 발현 량은 정상 쥐에 비해 현저하게 감소하는 것을 볼 수 있었다. 이중 8주 동안 저강도 운동 수행 한 쥐들의 경우는 정상 쥐 수준에 가까운 발현 량을 관찰 할 수 있었으며, 흰쥐 가자미 근 내 GRP-78 발현 량은 당뇨 유발 쥐의 경우 정상 쥐의 유의하게 증가한 것을 관찰할 수 있었고, 저강도 운동을 수행한 집단에서의 GRP-78 발현 량은 정상 흰쥐에서 발현되는 양에 비해 유의하게 높은 수준을 보이기는 했지만 당뇨 유발 대조군과 고강도 운동 군에 비해서는 유의하게 낮은 수준으로 나타났다. 결론적으로 저강도의 운동은 당뇨 질환자의 혈당을 낮추는 데 가장 효과적인 운동이라 할 수 있으며, 이러한 결과의 기전적인 원인은 저강도의 운동이 근육 내 GLUT-4의 증가로 세포내 당 유입을 촉진시킴으로 해서 나타난 사실이라 생각되며 이 같은 사실은 GRP-78의 발현 량의 감소로 확인할 수 있었다.